BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9885917)

  • 1. Mice lacking the transcription factor CIITA--a second look.
    Williams GS; Malin M; Vremec D; Chang CH; Boyd R; Benoist C; Mathis D
    Int Immunol; 1998 Dec; 10(12):1957-67. PubMed ID: 9885917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain.
    Itoh-Lindstrom Y; Piskurich JF; Felix NJ; Wang Y; Brickey WJ; Platt JL; Koller BH; Ting JP
    J Immunol; 1999 Sep; 163(5):2425-31. PubMed ID: 10452977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.
    Chang CH; Guerder S; Hong SC; van Ewijk W; Flavell RA
    Immunity; 1996 Feb; 4(2):167-78. PubMed ID: 8624807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.
    Benasciutti E; Mariani E; Oliva L; Scolari M; Perilli E; Barras E; Milan E; Orfanelli U; Fazzalari NL; Campana L; Capobianco A; Otten L; Particelli F; Acha-Orbea H; Baruffaldi F; Faccio R; Sitia R; Reith W; Cenci S
    J Bone Miner Res; 2014 Feb; 29(2):290-303. PubMed ID: 24038328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.
    Steimle V; Siegrist CA; Mottet A; Lisowska-Grospierre B; Mach B
    Science; 1994 Jul; 265(5168):106-9. PubMed ID: 8016643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the specificity of the MHC class II transactivator CIITA in vivo.
    Otten LA; Leibundgut-Landmann S; Huarte J; Kos-Braun IC; Lavanchy C; Barras E; Borisch B; Steimle V; Acha-Orbea H; Reith W
    Eur J Immunol; 2006 Jun; 36(6):1548-58. PubMed ID: 16703565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites.
    Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW
    Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
    Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
    J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative control of MHC class II expression by the transactivator CIITA.
    Otten LA; Steimle V; Bontron S; Mach B
    Eur J Immunol; 1998 Feb; 28(2):473-8. PubMed ID: 9521055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced production of IL-10 by dendritic cells deficient in CIITA.
    Yee CS; Yao Y; Xu Q; McCarthy B; Sun-Lin D; Tone M; Waldmann H; Chang CH
    J Immunol; 2005 Feb; 174(3):1222-9. PubMed ID: 15661876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival of class II transactivator-deficient cardiac allografts.
    June Brickey W; Felix NJ; Griffiths R; Zhang J; Wang B; Piskurich JF; Itoh-Lindstrom Y; Coffman TM; Ting JP
    Transplantation; 2002 Nov; 74(9):1341-8. PubMed ID: 12451276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes.
    Otten LA; Tacchini-Cottier F; Lohoff M; Annunziato F; Cosmi L; Scarpellino L; Louis J; Steimle V; Reith W; Acha-Orbea H
    J Immunol; 2003 Feb; 170(3):1150-7. PubMed ID: 12538670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.